Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan

This is the first study in which the carfilzomib, lenalidomide and dexamethasone (KRd) regimen was evaluated in heavily pretreated multiple myeloma. This study is a multicenter, open‐label phase 1 study of KRd in Japanese patients with relapsed or refractory multiple myeloma (RRMM) patients. The obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Kenshi, Ri, Masaki, Chou, Takaaki, Sugiura, Isamu, Takezako, Naoki, Sunami, Kazutaka, Ishida, Tadao, Izumi, Tohru, Ozaki, Shuji, Shumiya, Yoshihisa, Ota, Kenji, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378280/
https://www.ncbi.nlm.nih.gov/pubmed/28092421
http://dx.doi.org/10.1111/cas.13166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378280/
https://www.ncbi.nlm.nih.gov/pubmed/28092421
http://dx.doi.org/10.1111/cas.13166

Ejemplares similares